by admin_63069 | Feb 5, 2025 | Related Topics
This conversation explores potential therapeutic implications, biomarker development, and ongoing investigations into how different prostate cancer types might influence bone metastasis patterns.
by admin_63069 | Feb 3, 2025 | News You Can Use
It is important to consider disease volume, whether presentation with mCSPC is de novo, presence of comorbid conditions, and eligibility for docetaxel chemotherapy treatment.
by admin_63069 | Jan 29, 2025 | Related Topics
The year 2024 has been transformative for prostate cancer (PCa) and prostatic diseases, marked by advancements in basic science, diagnostic tools and novel therapeutic options.
by admin_63069 | Jan 27, 2025 | News You Can Use
Do they underestimate the risk of biochemical recurrence?
by admin_63069 | Jan 23, 2025 | Resources
WebMD Prostate Cancer Guide
